Archive ready

2025年5月期 第1四半期 決算説明資料

https://www.medical-net.com/common/doc/ir/r06/ir_r06_20241015_2.pdf
June 27, 2026 at 09:50 PM JSTThe archive page, viewer, and downloads use this saved version.
June 27, 2026 at 09:50 PM JST·www.medical-net.com

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved PDF

2025年5月期 第1四半期 決算説明資料

StartedJune 27, 2026 at 09:50 PM JST
File size4.12 MB
SHA-256b8ce428a1145721e2c37c9de6366aac021ff56f396c907c70747861947e4a595
About this pageAI generated

This document is the financial results presentation for the first quarter of the fiscal year ending May 2025, covering the period from June 2024 to August 2024. The revenue increased by 23.5% year-on-year to 1,358 million yen, while operating profit decreased from 22 million yen to a loss of 3 million yen, primarily due to a segment loss of 51 million yen in the pre-disease and prevention platform business. The outlook for the fiscal year ending May 2025 anticipates revenue of 6,400 million yen and operating profit of 330 million yen. The company plans to continue investing in human resources and new businesses to expand its operational scope.